Mapatumumab (Anti-TNFRSF10A / TRAILR1 / CD261), 1mg*25

Mapatumumab (Anti-TNFRSF10A / TRAILR1 / CD261), 1mg*25

Tomaralimab (Anti-TLR2 / CD282), 1mg*5

Tomaralimab (Anti-TLR2 / CD282), 1mg*5

Tomaralimab (Anti-TLR2 / CD282), 1mg

1.973,02 RON
SKU
SKM_A2333_1mg

Tomaralimab (Anti-TLR2 / CD282) is a humanized immunoglobulin (Ig) G4 monoclonal antibody directed against toll-like receptor type 2 (TLR2) with potential anti-inflammatory and antineoplastic activities. It has the potential for research on Myelodysplastic Syndromes (MDS). MW : 145.5 KD.

Mai multe informatii
Price 1.658,00 RON (preturile sunt fara TVA)
Description

Tomaralimab (Anti-TLR2 / CD282) is a humanized immunoglobulin (Ig) G4 monoclonal antibody directed against toll-like receptor type 2 (TLR2) with potential anti-inflammatory and antineoplastic activities. It has the potential for research on Myelodysplastic Syndromes (MDS). MW : 145.5 KD.